CoreAge Rx vs Voxy
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Voxy head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 63 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Voxy a bad call — it's best for readers comparing compounded injection plans who obtain the entire longer-term payment and cancellation calculation before selecting the lowest rate. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Voxy |
|---|---|---|
| Brief Score | 94/100 (A) | 63/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | $175 billed monthly Three-/six-/twelve-month options show $145/$120/$99 monthly equivalents, billed at the corresponding longer interval; full selected charge unconfirmed. Provider, prescribed medication, supplies and shipping advertised included. No-fee cancellation does not establish an unused-prepaid refund. Full price detailsCompounded semaglutide injection offered; complete selected-plan quote unknown; $175 monthly, or $145/$120/$99 monthly equivalents billed every three/six/twelve months; full longer-term charges not established |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | $225 billed monthly Three-/six-/twelve-month options show $199/$175/$135 monthly equivalents, billed at the corresponding longer interval; full selected charge unconfirmed. Confirm actual dose, quantity, shipment schedule and prepaid refund agreement before choosing the lowest equivalent. Full price detailsCompounded tirzepatide injection offered; complete selected-plan quote unknown; $225 monthly, or $199/$175/$135 monthly equivalents billed every three/six/twelve months; full longer-term charges not established |
| Coverage | US only; restrictions by state, confirmed at intake | Nationwide service advertised, subject to clinician licensure and pharmacy authorization for the patient’s state |
| Brand-name access | Not confirmed | Brand-name ingredient comparisons do not identify a current branded-prescription program. |
| Oral / sublingual | Injection only | Unconfirmed |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Voxy: Monthly semaglutide/tirzepatide $175/$225; lower equivalents require three-, six- or twelve-month billing. Full selected charge, supply and unused-prepaid refund remain unconfirmed.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.